(Reuters) – Moderna Inc said on Friday Swiss drugs regulator Swissmedic had authorized the use of its COVID-19 vaccine for children aged 6 to 11 years.

The approval is for the vaccine’s two-dose series of 50 micro gram per dose, Moderna added.

Source: Read Full Article